OBJECTIVE: @entity1 with @entity161 have increased risk of @entity731 . It is already known that lifestyle-related disorders and the use of antipsychotics are closely related with the progression of @entity731 in @entity146 @entity1 . @entity64 as well as @entity301 play an important role in the cause of @entity204 in Asia and Japan. Thus, we studied the prevalence of @entity66 in @entity146 inpatients in Japan using brain magnetic resonance imaging (MRI). METHOD: This cross-sectional study was performed from January 2012 to December 2013. Study @entity1 were 152 hospitalized @entity1 (61 @entity1 and 91 @entity1 ) in the Department of Psychiatry at Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa City, Japan. Mean ages were 50.0 and 57.1 years old for @entity1 and @entity1 , respectively. The diagnoses (DSM-IV-TR criteria) of @entity1 were @entity161 (69.1%), @entity1316 (18.4%), and other @entity146 (12.5%). We checked physical status, metabolic status of @entity413 and lipid levels, and brain MRI within 1 week of admission. RESULTS: The study group showed a significantly high prevalence of @entity6 and low high-density lipoprotein (HDL) cholesterolemia in both sexes (n = 61 in @entity1 , n = 91 in @entity1 , P < .05). In the study group, serum fasting plasma @entity413 and hemoglobin A1c levels were significantly high (n = 152, P < .05), but serum HDL @entity165 and total @entity165 were significantly low in both sexes (n = 61 in @entity1 , n = 90 in @entity1 , P < .05), and @entity1674 were low in @entity1 (n = 61, P < .05). Silent @entity4798 was recognized at a higher rate (n = 98, P < .05) compared with healthy controls. CONCLUSIONS: @entity1 in this study had an increased ratio of silent @entity4798 compared with Japanese healthy controls, accompanied with higher ratios of @entity6 and low HDL @entity165 .

Increased Silent Brain Infarction Accompanied With High Prevalence of @entity6 and Dyslipidemia in XXXX Inpatients: A Cross-Sectional Study.

@entity1 :: ('9606', 'Species') :: ['Participants', 'men', 'women', 'Patients', 'participants', 'patients'] @entity4798 :: ('MESH:D020520', 'Disease') :: ['brain infarction'] @entity64 :: ('MESH:D020521', 'Disease') :: ['Stroke'] @entity66 :: ('MESH:D004194', 'Disease') :: ['cerebrovascular disease'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes'] @entity146 :: ('MESH:D001523', 'Disease') :: ['psychiatric', 'mental disorders'] @entity301 :: ('MESH:D003327', 'Disease') :: ['coronary heart disease'] @entity1674 :: ('MESH:D014280', 'Chemical') :: ['triglycerides'] @entity1316 :: ('MESH:D019964', 'Disease') :: ['mood disorder'] @entity161 :: ('MESH:D012559', 'Disease') :: ['schizophrenia'] @entity731 :: ('MESH:D050197', 'Disease') :: ['atherosclerotic diseases', 'atherosclerosis'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose'] @entity165 :: ('MESH:D002784', 'Chemical') :: ['cholesterol']
@entity146 :: (MESH:D001523,Disease) :: ['Psychiatric']
